martes, 21 de julio de 2015

Media Availability: Alefacept Helps Preserve Function of Insulin-Producing Cells in Type 1 Diabetes

Media Availability: Alefacept Helps Preserve Function of Insulin-Producing Cells in Type 1 Diabetes



NIAID Logo



Monday July 20, 2015

Drug Protects Insulin-Producing Cells in Type 1 Diabetes

Pancreatic cells

Results from an NIAID-sponsored clinical trial suggest that the drug alefacept helps preserve function of insulin-producing pancreatic beta cells in people with newly diagnosed Type 1 diabetes. Alefacept treatment was safe, and the clinical benefits persisted for more than one year after treatment stopped.


Read More

No hay comentarios:

Publicar un comentario